Short Bowel Syndrome Market: How Is Intestinal Failure Driving Therapeutic Innovation?
The short bowel syndrome market — the commercial ecosystem for parenteral nutrition, GLP-2 analogs, intestinal rehabilitation programs, surgical interventions, and emerging gene and cellular therapies for patients with massive intestinal resection leading to intestinal failure — addresses one of medicine's most challenging chronic conditions, with the Short Bowel Syndrome Market...
0 แชร์
386 ยอดวิว
0 รีวิว
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
